

U.S. stocks fell Tuesday as health care lagged, while energy gained. ABM beat estimates; oil rose, and several biotech shares surged or plunged.
You can purchase shares of Lexaria Bioscience (NASDAQ:LEXX) through any online brokerage.
Other companies in Lexaria Bioscience’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Lexaria Bioscience has a consensus price target of $101.25.
The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $3.91 last updated November 3, 2026 at 4:12 PM EST.
There are no upcoming dividends for Lexaria Bioscience.
Lexaria Bioscience does not have any upcoming earnings scheduled.
There is no upcoming split for Lexaria Bioscience.
Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability...